On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
As we anticipate the likely approval of COVID-19 vaccination for children, our nation faces the final step to bring the COVID-19 pandemic under control. If approved for children ages 5-11, the ...
On this bonus episode of Public Health Review, we discuss how a business or government can create vaccine credentials that are more sophisticated than the paper cards from CDC, but that also protect ...
Our experts on this episode also discuss that while there have been perceived challenges in the initial COVID-19 vaccine rollout, the overall effort of getting vaccines into the arms of a virus that ...
On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
This bonus episode is taken from a virtual news conference on Thursday, July 29, 2021. In it, Nirav Shah (Maine), Karyl Rattay (Delaware), and Joseph Kanter (Louisiana), discuss the latest issues ...
Nirav Shah, Director of Maine Center for Disease Control and Prevention, and Joe Smyser, CEO of Public Good Projects, discuss countering COVID-19 vaccine misinformation.
Pharmacies have long been instrumental partners in providing lifesaving vaccines nationwide. As state and territorial health officials evaluate their COVID-19 response, planners must include input ...
There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and ...
Public health leaders are positioned to prevent illness from the "tripledemic” of COVID-19, Influenza, and RSV with approved vaccines and preventative antibody treatments.